Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis
NCT: NCT05633706 · ACTIVE_NOT_RECRUITING
Brief Summary
The SIMBA Capsule is a small, single-use, ingestible capsule that allows for the non-invasive sampling of small bowel contents using purely mechanical means. The study will compare the microbial and metabolomics analysis from the sample collected with the capsule series, to same-participant symptom questionnaires and stool microbial analysis.
Frequently Asked Questions
What is Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis?
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis is a clinical trial registered under NCT05633706. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05633706?
The current status of NCT05633706 (Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis) is: ACTIVE_NOT_RECRUITING.
When did Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis start?
Evaluation of the SIMBA Capsule for Small Intestinal Dysbiosis started on 2023-01-09.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.